Healthcare News Net

Increasing Elderly Population Call for More Spinal Treatments

In 2021, the interbody spine implants market was valued at $1,904.8 million and will reach $2,471.8 million by 2030, growing at a rate of about 3% during the forecast period. The major factors responsible for the development of the market are the improvements in the technologies of spine surgery, an increase in demand for devices for spinal fusion because of the surge in the incidence of spinal ailments, rapid acceptance of minimally invasive surgeries for the spine, and surge in the introduction of innovative bone-grafting products.
The interbody spine implants market of the APAC region will grow the fastest, with a growth rate of over 3.0%, by the end of this decade. Japan, India, China South Korea, and Australia contribute significantly to the regional market. This is because of the existence of a large patient population, a rise in consciousness of spinal disorders and treatment opportunities, enhancements in healthcare infrastructure, and an increase in healthcare spending. Furthermore, there is a presence of elderly population has a high risk of spinal ailments. The metal-based implants will have the highest demand of over 45% in the interbody spine implants market and will have the highest growth rate in the years to come. This has a lot to do with the high usage of metal-based implants in spine surgeries, because of their durability, suppleness, and robustness. Apart from that, these comprise metals like stainless steel, tantalum, and titanium. Asa per the AAOS, most spinal implants are made with a combination of titanium alloys, pure titanium, and stainless steel. Hospitals make the maximum use of interbody spine implants, as spine surgeries are performed here in large numbers for treating several spine ailments. They have over half of the total requirement for these implants. They have the ultimate nursing facility for spinal care with a joint approach to orthopedics and neuroscience. Similarly, the progressive healthcare facilities and skill of spine surgeons here are the primary reasons behind the expanding demand for spinal implants in hospitals. The demand for Interbody spine implants is on the rise in the world because of the increasing cases of DSD and the increase in the elderly population.

Professional Acne Treatment Market To Generate $13,124.5 Million Revenue by 2030 A number of factors, such as the increasing prevalence of acne, escalating disposable income of people in developing and developed countries, rising number of research programs, and mounting healthcare expenditure, are expected to drive the professional acne treatment market at a CAGR of 7.6% during 2020–2030. According to P&S Intelligence, the market was valued at $6,298.9 million in 2020, and it is projected to generate $13,124.5 million revenue by 2030. The global demand for professional acne treatment is driven by the surging incidence of acne in the adolescent and young populations. Acne vulgaris is a common dermatological disorder affecting a majority of the global population at some point during its life. For example, the American Academy of Dermatology (AAD) estimates that acne affects approximately 50 million Americans annually. As per the AAD, around 85% of the individuals aged 12–24 years are affected by at least minor acne. Moreover, the surging public awareness on physical appearance will facilitate the professional acne treatment market growth worldwide. Owing to the increased awareness, people across the world are heavily investing in comprehensive skincare routines for skin problems, such as acne and scars. Topical therapies, lasers, systemic agents, photodynamic therapies, and physical modalities are the most-common ways in which professional treat skin ailments. Furthermore, clinicians also recommend combination therapies to permanently reduce the occurrence of acne. The acne type segment of the professional acne treatment market is bifurcated into inflammatory and non-inflammatory. Of these, the inflammatory category generated the higher revenue in 2020 due to the surging need for an effective treatment for inflammatory acne, as it is usually painful. A large number of pharmaceutical companies are offering branded and generic drugs for inflammatory acne, as the commonly available benzoyl-peroxide and salicylic-acid-based over-the-counter (OTC) products are not completely effective on it. Geographically, North America accounted for the largest professional acne treatment market share during the historical period (2014–2020). This was due to the rising cases of acne, surging public awareness on newly developed drugs, and growing per capita income in the region. Moreover, the presence of a strong pipeline of major dermatology drug manufacturers, such as Pfizer Inc., Johnson & Johnson, and Bausch Health Companies Inc., will facilitate the market growth in North America. Therefore, the rising cases of acne and growing public awareness on physical appearance are the key facilitators of the market growth.
U.S. Endoscope Repair Market Revenue To Be $990.7 Million by 2030 From $405.6 million in 2021, the U.S. endoscope repair market is predicted to touch $990.7 million by 2030. The market is projected to grow at a 10.4% CAGR from 2021 to 2030 owing to a higher prevalence of respiratory, colorectal, and malignant gastrointestinal (GI) diseases than before; increasing number of hospitals, bettering quality of healthcare services, and highly competitive market players. Moreover, the increasing count of preventive treatments and diagnostic procedures due to a rising geriatric population will pave the way for an extensive usage of endoscopes.
The growing adoption of equipment insurance is one of the major trends in the U.S. endoscope repair market. There is a robust requirement for insurance because of the exorbitant maintenance costs of medical devices. To protect healthcare institutions from heavy losses owing to equipment damage and uncertainties, medical device insurance is offered by numerous corporations. They include DESCO, American International Group Inc., Anco Insurance, Medical Equipment Repair Associates, ProTek Insurance, Cailor Fleming Insurance, and CAN Financial Corporation. The U.S. endoscope repair market is bifurcated into OEMs and ISOs, on segmentation by service provider. ISOs will exhibit a higher rate of growth, of more than 10%, in the coming years. This can be ascribed to the advantages of contracting ISOs, including better flexibility and lower expenses in repairing and servicing the endoscope equipment of different OEMs. Furthermore, attempts to alleviate the additional expenses and complexities linked with different services under contract with various OEMs can be made through the greater adoption of comprehensive repair & maintenance contracts with ISOs. There is a boundless U.S. endoscope repair market growth opportunity in Texas. The state market is predicted to witness the highest compound annual growth rate from 2021 to 2030. This can be credited to a swift spread of cancer, coupled with a boom in the aged population in the state. Moreover, the Texas Teacher Retirement System (TRS), Department of State Health Services (DSHS), Employees Retirement System (ERS), and Department of Aging and Disability Services (DADS) account for approximately 83% of the annual healthcare expenditure, raising its affordability among the masses. With the growing count of gastrointestinal and colorectal infection cases, the count of endoscopy procedures for treatment and diagnosis has been surging. The incidence of GI and benign disorders, along with colorectal problems, is on a significant rise. Similarly, disorders including biliary and pancreatic diseases are very much prevalent among the aged population. On account of efficacy and safety concerns, there is an inclination of patients and doctors toward the usage of endoscopes for the diagnosis of tumors.

With Rising Geriatric Population, ENT Devices Market To Cross $30 Billion by 2030

The major driver for the ENT devices market is the growing incidence of disorders related to the ear, nose, and throat, such as sinusitis and hearing problems; rising demand for minimally invasive ENT procedures, and burgeoning spending on healthcare around the world. Because of all these factors, the revenue generated by the devices used in such procedures is expected to witness a 6.9% CAGR, to reach $31,805.3 million by 2030 from $17,439.8 million in 2021. Hospitals generate over 40% of the revenue for the market players, based on end user, because they are the preferred point of contact for people with health issues. Moreover, with governments constructing new hospitals, the procurement of ENT devices by such entities will burgeon in the coming years. Further, ENT clinics will be the fastest-advancing category over the forecast period because the treatment offered at such places costs much less than one offered at a full-fledged hospital. Another major reason behind the advance of the ENT devices market is the burgeoning aging population. The elderly are prone to ENT diseases, especially hearing loss and throat infections, because of their physical weakness and compromised immunity. According to the UN, there were 727 million people in the age group of 65 and above in 2020, and their population will rise to 1.5 billion by 2050. This is expected to boost the volume of ENT procedures at all kinds of medical settings, thereby driving the demand for the devices used during them. North America currently dominates the ENT devices market because of the high prevalence of related diseases, high healthcare spending, and advanced medical infrastructure. For instance, in the U.S., 10% of the adult people suffer from chronic rhinitis each year. Further, the medical insurance ecosystem in the region is rather developed, which offers the masses access to ENT procedures. In addition, a large number of domestic and international medical device manufacturers operate in the U.S. and Canada, thus resulting the easy availability of the equipment. During the decade, APAC will grow considerably fast in the market as it is home to the largest patient population in the world. Further, the geriatric population of India and China is the largest on earth, as is the incidence of diseases of the nose, ear, and throat. Additionally, governments of regional countries are augmenting their spending on the improvement of healthcare services, which is driving the volume of ENT procedures. Moreover, seeing the lucrative opportunity, overseas medical device manufacturers are strengthening their focus on the APAC region. Thus, the rising prevalence of ENT diseases, especially among the elderly, is propelling the market.

How Does Robotic Surgery Work?

Contrasting open surgery, MIS lets doctors to operate with less impairment to the body, causing a lesser amount of pain, less complications, and shorter hospital stay for patients. For instance, laparoscopy, one of the better-known minimally invasive surgery, usages small incisions to pass small tubes, cameras and devices so doctors can work without a conventional surgical method.
Another this kind of surgery is robotic surgery, in which medics can make numerous complex procedures with added accuracy, suppleness, and control because they are assisted by a robot that improves their competences and helps them overcome numerous limitations of surgical procedures.
Defining Robotic Surgery
Robotic surgery is an advanced surgery using robots to do what people can’t. Considering how bulky human hands are as opposed to robotic arms, which can be thinner while retaining a high dexterity allowing manoeuvring in tight places in the body. Additionally, when you present automatic elements paired with feedback-controlled surgery motions, you get much smoother actions than human hands. This gives surgeons more control on surgeries while also plummeting tissue trauma.
How Does Robotic Surgery Work? While there are numerous robotic surgery procedures, the enormous majority will include a surgeon sitting at a distinct console with controls at foot and hand allowing remotely and exactly control surgical tools attached to robotic arms. Alterations can also be done to alter the scale of the robot’s movement.
Instruments Used in Robotic Surgery Usually, robotic surgery is done with the da Vinci Surgical System, having FDA approval for use in surgeries including: ● Cardiac: Where apt, minimally invasive procedure is done and not open heart surgery. ● Colorectal: Colon and rectal resection surgery, along with rectopexy can be done with the help of robot. ● General surgery: General surgery comprises numerous procedures like inguinal hernia repair that can be done with the help of robots. ● Gynecology: Doctors may suggest robotic benign hysterectomy. ● Head and neck: Transoral robotic surgery might be an alternative for mouth and throat surgery. ● Thoracic: When surgery for lung cancer is to be done, doctors might choose robotic surgery. ● Urology: Doctors might advise robotic surgery for urology procedures for kidney or prostate.
Compensations of Robotic Surgery There are several advantages of robotic surgeries. For instance, the fact that operation is done through a small incision implies that there is less pain along with negligeable scarring, briefer hospitalization, and faster recovery. The use of HD 3D cameras gives improved visualization as surgeons gain close-up of areas not accessible in conventional surgery. Similarly, the use of robotic arms mimicking the movement of hands offer surgeons with improved deftness and greater accuracy than could ever be possible with conformist surgical instruments.

Medical Electrodes Market Expected to Witness Considerable Growth in Coming Years

With the rising volume of minimally invasive procedures, booming geriatric population, and increasing prevalence of lifestyle-associated and chronic diseases, the usage of medical electrodes is surging. As a result, the global medical electrodes market is predicted to grow at a 6.7% CAGR between 2021 and 2025 (forecast period), to reach $1,151.6 million by 2025. During the first quarter of 2020, the lockdowns and movement restrictions imposed in the wake of the COVID-19 pandemic affected the medical electrodes market negatively, as the production and trade of such products came to a standstill. However, as the manufacturing sector began rebounding in the second quarter, the supply of medical electrodes to an already stressed healthcare sector resumed, which will now continue pushing up the market value in the coming years. Demand for Disposable Electrodes To Rise Faster Reusable and disposable are the bifurcations of the medical electrodes market when it is segmented based on usability. Of these, the higher CAGR during the forecast period will be seen in the disposable bifurcation, as disposable electrodes are easy to use and cost-effective, do not need to be sterilized, and carry a minimal risk of hospital-acquired infections (HAI). On segmenting the market on the basis of modality, the categories are electroencephalography (EEG) & brainstem auditory evoked potential (BAEP), electrocardiography (ECG), electromyography (EMG), and others. Among these, the ECG category dominated the medical electrodes market in 2020 due to the already high prevalence of cardiovascular disorders, including coronary artery disease, arrhythmias, and atherosclerosis, which continues to surge. An ECG maps the flow of electrical current through the heart muscle, to give an idea of the heart rhythm in the form of a graph. Additionally, this test vaguely informs doctors of the blood flow into, within, and out of the heart. Since both these parameters are important in diagnosing a range of chronic diseases, the healthcare sector conducts a high volume of ECGs every day; hence, the demand for the associated electrodes is quite high. During the forecast period, Asia-Pacific (APAC) is projected to be the fastest-growing medical electrodes market, on account of its large population of the elderly, increasing spending on healthcare, and rising incidence of chronic diseases.

Growing Prevalence of Autoimmune Diseases to Fuel $10,012.9 Million Revenue in Global Autoimmune Disease Diagnostics Market in 2030

The rising incidence of autoimmune diseases, growing geriatric population, advent of novel biomarkers, increasing initiatives being taken by various government and private organizations for raising public awareness about autoimmune diseases, and the soaring strategic development projects and activities being launched by the market players are the key factors fueling the expansion of the global autoimmune disease diagnostics market. Furthermore, the market is predicted to attain a valuation of $10,012.9 million in 2030, exhibiting a CAGR of 8.5% from 2020 to 2030. Based on product, the autoimmune disease diagnostics market is categorized into instruments and consumables and assay kits. Of these, the consumables and assay kits category is predicted to dominate the market in the future years, on account of the growing incidence of autoimmune diseases and the rising requirement for tests, such as enzyme-linked immunosorbent assay (ELISA), rheumatoid factor (RF) & anti-cyclic citrullinated peptide (CCP) antibody, and antinuclear antibody (ANA) immunofluorescence assay (IFA).
Globally, the North American autoimmune disease diagnostics market is predicted to exhibit lucrative growth in the upcoming years, owing to the rapid improvements in healthcare facilities and infrastructure, growing prevalence of autoimmune diseases, rising research activities, soaring geriatric population, and the existence of several leading market players in the region. The players operating in the global autoimmune disease diagnostics market are increasingly focusing on developing and commercializing products for enhancing their market position. For example, F. Hoffmann-La Roche Ltd. announced in September 2019 that it had received approval from the USFDA (United States Food and Drug Administration) for the usage of the cobas Babesia test on the cobas 6800/8800 systems. This test would be used for testing the blood donated by individuals and it follows the May 2019 updated guidelines of the FDA which recommend the screening and testing of donated blood for Babesia for reducing the chances of the transmission of the parasite through transfusions.

Data Management by E-Clinical Solutions Enhance Clinical Trials

E-clinical solutions are used by healthcare providers, contract research organizations (CROs), and pharmaceutical and biotechnology companies, to acquire, manage, convert, and standardize data. Owing to such features, e-clinical solutions are widely used for clinical trials conducted by pharmaceutical and biotechnology companies. Furthermore, the CROs are using such solutions for supporting the pharmaceutical and medical device sectors, by offering research services, such as biopharmaceutical development, clinical trials management, preclinical research, clinical research, and biological assay management, on a contractual basis.
Adoption of e-clinical solutions has accelerated, due to rising attempts to invent treatments for diseases like cancer, acquired immunodeficiency syndrome (AIDS), and diabetes. These attempts have encouraged pharmaceutical, biopharmaceutical, clinical research, and life sciences firms to invest hefty amounts in the development of e-clinical solutions market. Furthermore, surging incidence of cancer and diabetes will increase the application of e-clinical solutions. For example, the World Health Organization (WHO) states that cancer accounts for nearly 9.6 million deaths, annually. Whereas, the International Diabetes Federation (IDF) estimates that around 629 million people will suffer with diabetes, globally, by 2045. Additionally, booming ageing population will accelerate the requirement of e-clinical solutions, as the elderly are highly susceptible to chronic diseases like cancer, diabetes, and cardiovascular diseases (CVDs). According to the United Nations Department of Economic and Social Affairs (UNDSEA), the population size of individuals aged 65 years or above will reach 225.4 million in India, 356.6 million in China, 84.8 million in the U.S., and 52.0 million in Brazil, by 2050. They require better drugs due to the rising complexities in life-threatening diseases, on account of climatic abnormalities and changing lifestyle pattern. Another factor driving the demand for such solutions is the government efforts to digitally transform their medical infrastructure. For instance, as part of its Health Information Technology for Economic and Clinical Health (HITECH) Act, the U.S. government incentivizes healthcare professionals who use digital technologies. Similarly, in 2015, the European Union (EU) announced plans to invest $18.1 million for developing the digital health infrastructure in the region, so that as many medical services as possible can be dispensed virtually, thereby resulting in time and cost savings for patients as well as caregivers. According to P&S Intelligence, North America dominates the e-clinical solutions market, due to the surging expenditure on research and development (R&D) by pharmaceutical and biotechnology companies. Whereas, the Asia-Pacific (APAC) market will exhibit the fastest growth in coming years, on account of growth in clinical trial outsourcing in emerging economies like India and China. Clinical trials in these countries are escalating, owing to cost-efficiency and availability of a large number of patients in these nations. Pharmaceutical companies in APAC are constantly focusing on clinical trials, thereby, amplifying the application of e-clinical solutions. With the high penetration of chronic diseases and the vast population size of the elderly, coupled with rising number of R&D activities by pharmaceutical and biotechnology companies, the adoption of e-clinical solutions will escalate, globally.

Rising Diabetes Cases Driving Surgical Sutures Demand in Saudi Arabia

The U.S. Centers for Disease Control and Prevention (CDC) states that stroke, cirrhosis, diabetes, ischemic heart disease, chronic kidney disease, lower respiratory infections, and neonatal disorders are the leading causes of death in Saudi Arabia. According to the Ministry of Health, under the Kingdom of Saudi Arabia, diabetes is one of the most prevalent diseases in the country. As per the Ministry, diabetes causes cardiovascular diseases (CVDs), nerve damage, kidney damage, eye damage, cancer, and Alzheimer's disease among the affected population.
A majority of chronic diseases caused due to diabetes require surgeries, therefore, the increasing incidence of chronic diseases will help the Saudi Arabian surgical sutures market to progress at 3.6% CAGR during 2018–2023. According to P&S Intelligence, the market was valued at $16.7 million in 2017 and it is expected to generate $20.6 million revenue by 2023. As diabetes and chronic diseases are extremely common among old people, a surge in their population will also create a huge requirement for surgical sutures in Saudi Arabia in the foreseeable future.
Moreover, the soaring number of hospitals and healthcare professionals will also augment the need for surgical sutures in the country in the upcoming years. As per the Ministry of Health, there were 89,093 nurses, 41,201 physicians, and 78,596 hospitals in Saudi Arabia in 2020. These hospitals and healthcare professionals use absorbable and non-absorbable sutures and reusable and disposable automated suturing devices while performing surgical procedures on patients, which, in turn, drive the demand for surgical sutures in the country. At present, companies operating in the Saudi Arabian surgical sutures market are focusing on mergers and acquisitions to offer improved products that can be used in general surgeries, orthopedic surgeries, gynecological surgeries, CVD surgeries, and ophthalmic surgeries. For instance, in January 2016, Surgical Specialties Corporation acquired all the affiliated entities and shares of FSSB Chirurgische Nadeln GmbH, a suture and needle manufacturing company, for $147 million. Through this acquisition, the former aims to expand its needle business by using the proprietary technology of the latter. Thus, the rising cases of chronic diseases and burn injuries and the increasing number of hospitals and healthcare professionals will create a huge requirement for surgical sutures in Saudi Arabia in the foreseeable future.

Surgical, Face, and Respiratory Mask Market To Generate $15,696.2 Million Revenue by 2030 A number of factors, such as the soaring air pollution levels, surging volumes of surgeries, booming geriatric population, and increasing prevalence of airborne diseases, will drive the surgical, face, and respiratory mask market at a CAGR of 5.7% during the forecast period (2020–2030). According to P&S Intelligence, the market generated a revenue of $2,141.3 million in 2019 and it is projected to reach $15,696.2 million by 2030. Moreover, the COVID-19 outbreak has also facilitated the market growth, worldwide.
The rising air pollution level is one of the prominent growth drivers for the market. Rapid industrialization and urbanization have led to the emission of a large volume of pollutants in the atmosphere. The increasing number of vehicles and manufacturing units, on account of urbanization and industrialization, are harming the air quality in numerous ways. The soaring air pollution level is resulting in lung cancer, respiratory infections, chronic lung diseases, and heart diseases and strokes. To avoid falling prey to these ailments, people are using surgical, face, and respiratory masks in abundance. The product type segment of the surgical, face, and respiratory mask market is divided into surgical and respiratory. Of these, the respiratory category is expected to account for larger market share in the forecast years, owing to the high air pollution levels and high prices of respiratory masks. Whereas, the surgical category will demonstrate faster growth in the coming years, due to the surging incidence of airborne diseases and increasing volume of surgeries. Moreover, the COVID-19 pandemic has augmented the sale of surgical masks, as these help in minimizing the spread of the virus. Geographically, Asia-Pacific (APAC) held the largest share in the surgical, face, and respiratory mask market in 2019, and it is projected to retain its dominance in the coming years as well. This can be attributed to high air pollution levels and increasing prevalence of airborne diseases, which compel people to wear masks, while commuting or going out. Moreover, the rampant spread of coronavirus in APAC countries has also fueled the demand for such masks. Besides, increasing number of hospitals and healthcare professionals have also supported the growth of the regional market. Thus, the rapid spread of coronavirus and the high air pollution levels will augment the demand for surgical, face, and respiratory masks in the forecast years, across the world. Read the full report - Surgical, Face and Respiratory Mask Market Insight